Browse > Article
http://dx.doi.org/10.1186/s40824-018-0147-5

Silicone breast implant modification review: overcoming capsular contracture  

Shin, Byung Ho (Department of Biomedical Engineering, Seoul National University College of Medicine)
Kim, Byung Hwi (Department of Biomedical Engineering, Seoul National University College of Medicine)
Kim, Sujin (Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University)
Lee, Kangwon (Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University)
Choy, Young Bin (Department of Biomedical Engineering, Seoul National University College of Medicine)
Heo, Chan Yeong (Interdisciplinary Program for Bioengineering, College of Engineering, Seoul National University)
Publication Information
Biomaterials Research / v.22, no.4, 2018 , pp. 319-327 More about this Journal
Abstract
Background: Silicone implants are biomaterials that are frequently used in the medical industry due to their physiological inertness and low toxicity. However, capsular contracture remains a concern in long-term transplantation. To date, several studies have been conducted to overcome this problem. This review summarizes and explores these trends. Main body: First, we examined the overall foreign body response from initial inflammation to fibrosis capsule formation in detail and introduced various studies to overcome capsular contracture. Secondly, we introduced that the main research approaches are to inhibit fibrosis with anti-inflammatory drugs or antibiotics, to control the topography of the surface of silicone implants, and to administer plasma treatment. Each study examined aspects of the various mechanisms by which capsular contracture could occur, and addressed the effects of inhibiting fibrosis. Conclusion: This review introduces various silicone surface modification methods to date and examines their limitations. This review will help identify new directions in inhibiting the fibrosis of silicone implants.
Keywords
Fibrosis; Inflammation; Silicone implant; Foreign body reaction; Capsular contracture; Modification;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Suzawa H, Kikuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn. J. Pharmacol. 1992;60(2):91-6.   DOI
2 Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol. 1997;16(6):664-73.   DOI
3 Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, et al. Airway remodeling in asthma. Chest. 2003;123(3):417S-22S.
4 Smith TL, Sautter NB. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis? Laryngoscope. 2014;124(8):1735-6.   DOI
5 Ashcroft GS. Bidirectional regulation of macrophage function by $TGF-{\beta}$. Microbes Infect. 1999;1(15):1275-82.   DOI
6 Wahl SM. Transforming growth factor beta ($TGF-{\beta}$) in inflammation: a cause and a cure. J Clin Immunol. 1992;12(2):61-74.   DOI
7 Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB. Immunodetection and quantitation of the two forms of transforming growth factor-beta ($TGF-{\beta}1$ and $TGF-{\beta}2$) secreted by cells in culture. J Cell Physiol. 1989;138(1):79-86.   DOI
8 Tintinger GR, Feldman C, Theron AJ, Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist? Sci World J. 2010;10:2403-13.   DOI
9 Jones T, Labelle M, Belley M, Champion E, Charette L, Evans J, et al. Pharmacology of montelukast sodium ($Singulair^{TM}$), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1995;73(2):191-201.   DOI
10 Peters-Golden M, Gleason M, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006;36(6):689-703.   DOI
11 Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med. 2007;357(18):1841-54.   DOI
12 Mastalerz L, Kumik J. Antileukotriene drugs in the treatment of asthma. Pol Arch Med Wewn. 2010;120(3):103-8.
13 Pines M, Nagler A. Halofuginone: a novel antifibrotic therapy. Gen. Pharmacol. Vasc. S. 1998;30(4):445-50.   DOI
14 Granot I, Halevy O, Hurwitz S, Pines M. Halofuginone: an inhibitor of collagen type I synthesis. Biochim. Biophys. Acta Gen. Subj. 1993;1156(2):107-12.   DOI
15 McGaha TL, Bona C, Phelps RG, Spiera H. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-${\beta}$-mediated Smad3 activation in fibroblasts. J Investig Dermatol. 2002;118(3):461-70.   DOI
16 Zeplin PH, Larena-Avellaneda A, Schmidt K. Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis. Plast Reconstr Surg. 2010;126(1):266-74.   DOI
17 Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008; Elsevier.
18 Champaneria MC, Wong WW, Hill ME, Gupta SC. The evolution of breast reconstruction: a historical perspective. World J Surg. 2012;36(4):730-42.   DOI
19 Malahias M, Jordan D, Hughes L, Hindocha S, Juma A. A literature review and summary of capsular contracture: An ongoing challenge to breast surgeons and their patients. International Journal of Surgery Open. 2016;3:1-7.
20 Headon H, Kasem A, Mokbel K. Capsular contracture after breast augmentation: an update for clinical practice. Archives of plastic surgery. 2015;42(5):532.   DOI
21 Cronin TD. Augmentation mammaplasty: a new" natural feel" prosthesis. Transact, III Internat Congr Plast Surg. 1964.
22 Hester T, Tebbetts JB, Maxwell GP. The polyurethane-covered mammary prosthesis: facts and fiction (II). Clin Plast Surg. 2001;28(3):579-86.
23 Luu H, Hutter JC, Bushar HF. A physiologically based pharmacokinetic model for 2, 4-toluenediamine leached from polyurethane foam-covered breast implants. Environ Health Perspect. 1998;106(7):393.   DOI
24 Brown MH, Shenker R, Silver SA. Cohesive silicone gel breast implants in aesthetic and reconstructive breast surgery. Plast Reconstr Surg. 2005;116(3):768-79.   DOI
25 Fruhstorfer BH, Hodgson EL, Malata CM. Early experience with an anatomical soft cohesive silicone gel prosthesis in cosmetic and reconstructive breast implant surgery. Ann Plast Surg. 2004;53(6):536-42.   DOI
26 Heden P, Jernbeck J, Hober M. Breast augmentation with anatomical cohesive gel implants: the world's largest current experience. Clin Plast Surg. 2001;28(3):531-52.
27 Siggelkow W, Faridi A, Spiritus K, Klinge U, Rath W, Klosterhalfen B. Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials. 2003;24(6):1101-9.   DOI
28 Kyle DJ, Oikonomou A, Hill E, Bayat A. Development and functional evaluation of biomimetic silicone surfaces with hierarchical micro/nano-topographical features demonstrates favourable in vitro foreign body response of breastderived fibroblasts. Biomaterials. 2015;52:88-102.   DOI
29 Cappellano G, Ploner C, Lobenwein S, Sopper S, Hoertnagl P, Mayerl C, et al. Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces. PLoS One. 2018;13(2):e0192108.   DOI
30 Wick G, Backovic A, Rabensteiner E, Plank N, Schwentner C, Sgonc R. The immunology of fibrosis: innate and adaptive responses. Trends Immunol. 2010;31(3):110-9.   DOI
31 Rolfe B, Mooney J, Zhang B, Jahnke S, Le S-J, Chau Y-Q, et al. The fibrotic response to implanted biomaterials: implications for tissue engineering. Regenerative medicine and tissue engineering-cells and biomaterials: InTech; 2011.
32 Luttikhuizen DT, Harmsen MC, Luyn MJV. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng. 2006;12(7):1955-70.   DOI
33 Klopfleisch R, Jung F. The pathology of the foreign body reaction against biomaterials. J Biomed Mater Res A. 2017;105(3):927-40.
34 Williams DF. On the nature of biomaterials. Biomaterials. 2009;30(30):5897-909.   DOI
35 Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31(1):81-110.   DOI
36 Vroman L, Adams A, Fischer G, Munoz P. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood. 1980;55(1):156-9.   DOI
37 Latour RA. Biomaterials: protein-surface interactions. Encyclopedia of biomaterials and biomedical engineering. 2005;1:270-8.
38 Zhang L, Cao Z, Bai T, Carr L, Ella-Menye J-R, Irvin C, et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol. 2013;31(6):553.   DOI
39 Horbett T. The role of adsorbed proteins in tissue response to biomaterials. Biomaterials science: an introduction to. materials in medicine. 2004;2:237-46.
40 Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005;97(11):1093-107.   DOI
41 Clark RA. The molecular and cellular biology of wound repair: Springer Science & Business Media; 2013.
42 Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng. 2005;11(1-2):1-18.   DOI
43 Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997;2(1):d12-26.   DOI
44 Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191.   DOI
45 Zhang J-M, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27.   DOI
46 Lefkowitz DL, Lefkowitz SS. Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol Cell Biol. 2001;79(5):502-6.   DOI
47 Chaudhary N, Roth G, Hilberg F, Muller-Quernheim J, Prasse A, Zissel G, et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29(5):976-85.   DOI
48 Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart FX, et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy. 2002;32(2):237-46.   DOI
49 Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000;177(1):195-203.   DOI
50 Kobayashi SD, Voyich JM, Whitney AR, DeLeo FR. Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor. J Leukoc Biol. 2005;78(6):1408-18.   DOI
51 Leask A, Abraham DJ. $TGF-{\beta}$ signaling and the fibrotic response. FASEB J. 2004;18(7):816-27.   DOI
52 Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, et al. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling. PLoS One. 2014;9(4):e92273.   DOI
53 Kreuger J, Phillipson M. Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. Nat Rev Drug Discov. 2016;15(2):125.   DOI
54 Sheikh Z, Brooks PJ, Barzilay O, Fine N, Glogauer M. Macrophages, foreign body giant cells and their response to implantable biomaterials. Materials. 2015;8(9):5671-701.   DOI
55 Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23.   DOI
56 Coleman DJ, Foo IT, Sharpe DT. Textured or smooth implants for breast augmentation? A prospective controlled trial. Br J Plast Surg. 1991;44(6):444-8.   DOI
57 Xia Z, Triffitt JT. A review on macrophage responses to biomaterials. Biomed Mater. 2006;1(1):R1.   DOI
58 Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med. 2011;13.
59 Brett D. A review of collagen and collagen-based wound dressings. Wounds. 2008;20(12):347-56.
60 Pajkos A, Deva AK, Vickery K, Cope C. Significant Breast Implant Capsules. Plast Reconstr Surg. 2003.
61 Hall-Findlay EJ. Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg. 2011;127(1):56-66.   DOI
62 Wong C-H, Samuel M, Tan B-K, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118(5):1224-36.   DOI
63 Stevens WG, Nahabedian MY, Calobrace MB, Harrington JL, Capizzi PJ, Cohen R, et al. Risk factor analysis for capsular contracture: a 5-year Sientra study analysis using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg. 2013;132(5):1115-23.   DOI
64 Brohim RM, Foresman PA, Hildebrandt PK, Rodeheaver GT. Early tissue reaction to textured breast implant surfaces. Ann Plast Surg. 1992;28(4):354-62.   DOI
65 Spano A, Palmieri B, Taidelli TP, Nava M. Reduction of capsular thickness around silicone breast implants by zafirlukast in rats. Eur Surg Res. 2008;41(1):8-14.   DOI
66 Sforza M, Zaccheddu R, Alleruzzo A, Seno A, Mileto D, Paganelli A, et al. Preliminary 3-year evaluation of experience with SilkSurface and VelvetSurface Motiva silicone breast implants: a single-center experience with 5813 consecutive breast augmentation cases. Aesthet Surg J. 2017.
67 Park S, Park M, Kim BH, Lee JE, Park HJ, Lee SH, et al. Acute suppression of $TGF-{\beta}$ with local, sustained release of tranilast against the formation of fibrous capsules around silicone implants. J Control Release. 2015;200:125-37.   DOI
68 Kim BH, Park M, Park HJ, Lee SH, Choi SY, Park CG, et al. Prolonged, acute suppression of cysteinyl leukotriene to reduce capsular contracture around silicone implants. Acta Biomater. 2017;51:209-19.   DOI
69 Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA surgery. 2017;152(12):1161-8.   DOI
70 Nagakura T, Hirata H, Tsujii M, Sugimoto T, Miyamoto K, Horiuchi T, et al. Effect of viscous injectable pure alginate sol on cultured fibroblasts. Plast Reconstr Surg. 2005;116(3):831-8.   DOI
71 Friedman H, Stonerock C, Lefaivre J, Yost M. The effect of seprafilm and interceed on capsule formation around silicone discs in a rat model. J Investig Surg. 2004;17(5):271-81.   DOI
72 Park SO, Han J, Minn KW, Jin US. Prevention of capsular contracture with $Guardix-SG^{(R)}$ after silicone implant insertion. Aesthet Plast Surg. 2013;37(3):543-8.   DOI
73 Lew DH, Yoon JH, Hong JW, Tark KC. Efficacy of antiadhesion barrier solution on periimplant capsule formation in a white rat model. Ann Plast Surg. 2010;65(2):254-8.   DOI
74 Barnea Y, Hammond DC, Geffen Y, Navon-Venezia S, Goldberg K. Plasma activation of a breast implant shell in conjunction with antibacterial irrigants enhances antibacterial activity. Aesthet Surg J. 2018;1:9.
75 Rieger U, Mesina J, Kalbermatten D, Haug M, Frey H, Pico R, et al. Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg. 2013;100(6):768-74.   DOI
76 Prantl L, Poppl N, Horvat N, Heine N, Eisenmann-Klein M. Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor? Aesthet Plast Surg. 2005;29(6):510-8.   DOI
77 Jacombs A, Allan J, Hu H, Valente PM, Wessels WL, Deva AK, et al. Prevention of biofilm-induced capsular contracture with antibiotic-impregnated mesh in a porcine model. Aesthet Surg J. 2012;32(7):886-91.   DOI
78 Giordano S, Peltoniemi H, Lilius P, Salmi A. Povidone-iodine combined with antibiotic topical irrigation to reduce capsular contracture in cosmetic breast augmentation: a comparative study. Aesthet Surg J. 2013;33(5):675-80.   DOI
79 Shintani H, Sakudo A, Burke P, McDonnell G. Gas plasma sterilization of microorganisms and mechanisms of action. Exp. Ther. Med. 2010;1(5):731-8.   DOI
80 Bazaka K, Jacob MV, Crawford RJ, Ivanova EP. Plasma-assisted surface modification of organic biopolymers to prevent bacterial attachment. Acta Biomater. 2011;7(5):2015-28.   DOI
81 Kylian O, Sasaki T, Rossi F. Plasma sterilization of Geobacillus stearothermophilus by O 2: N 2 RF inductively coupled plasma. Eur. Phys. J. Appl. Phys. 2006;34(2):139-42.   DOI
82 Joyce D, Steer J, Abraham L. Glucocorticoid modulation of human monocyte/macrophage function: control of $TNF-{\alpha}$ secretion. Inflamm Res. 1997;46(11):447-51.   DOI
83 Schreml S, Heine N, Eisenmann-Klein M, Prantl L. Bacterial colonization is of major relevance for high-grade capsular contracture after augmentation mammaplasty. Ann Plast Surg. 2007;59(2):126-30.   DOI
84 Yalanis GC, Liu E-W, Cheng H-T. Efficacy and safety of povidone-iodine irrigation in reducing the risk of capsular contracture in aesthetic breast augmentation: a systematic review and meta-analysis. Plast Reconstr Surg. 2015;136(4):687-98.   DOI
85 Schleimer R. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol. 1993;45(1):S3-7.   DOI
86 Amano Y, Lee SW, Allison AC. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol. 1993;43(2):176-82.
87 Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233.   DOI
88 Jeon BS, Shin BH, Huh BK, Kim BH, Kim S-N, Ji HB, et al. Silicone implants capable of the local, controlled delivery of triamcinolone for the prevention of fibrosis with minimized drug side effects. J Ind Eng Chem. 2018.
89 Ikeda H, Inao M, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor ${\beta}1$ expression in cultured rat stellate cells. Biochem Biophys Res Commun. 1996;227(2):322-7.   DOI
90 Prud'Homme GJ. Pathobiology of transforming growth factor ${\beta}$ in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Investig. 2007;87(11):1077.   DOI